Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Growth inhibition of ovarian tumor-initiating cells by niclosamide

ABSTRACT: The gene expression profile in treated CP70 side population spheroid cells (CP70sps cells) was analyzed to investigate the effect of niclosamide inhibition on ovarian tumor-initiating cells. CP70sps cells are isolated and characterized as one kind of ovarian tumor-initiating cells, and they show stemness properties and drug resistance capacity. According gene expression profiles and mechanistic analysis, all evidences revealed niclosamide disrupted multiple metabolic pathways affecting biogenetics, biogenesis and redox regulation. These studies support niclosamide as a promising therapeutic agent for ovarian cancer. CP70sps cells were treated with niclosamide for 0, 2, 4 and 6 hours respectively, and then cells were harvested and analyzed their gene expression profiles.

ORGANISM(S): Homo sapiens

SUBMITTER: Hung-Cheng Lai 

PROVIDER: E-GEOD-36259 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

A recent hypothesis for cancer chemoresistance posits that cytotoxic survival of a subpopulation of tumor progenitors drives the propagation of recurrent disease, underscoring the need for new therapeutics that target such primitive cells. To discover such novel compounds active against drug-resistant ovarian cancer, we identified a subset of chemoresistant ovarian tumor cells fulfilling current definitions of cancer-initiating cells from cell lines and patient tumors using multiple stemness phe  ...[more]

Similar Datasets

Unknown Growth inhibition of ovarian tumor-initiating cells by niclosamide
2012-08-06 | GSE36259 | GEO
Unknown Effects of spheroid and adherent growth conditions in ovarian cancer
2020-10-03 | GSE158949 | GEO
Transcriptomics Transcription profiling by array of the effect of hypoxia in tumour-initiating cells derived from a colorectal cancer patient
2020-02-01 | E-MTAB-7354 | biostudies-arrayexpress
Genomics Immune Resistance Emerges from Tumor-Initiating Stem Cells
| PRJNA428248 | ENA
Unknown Mouse mammary tumor-initiating cells
2008-06-27 | GSE8863 | GEO
Unknown Effects of RELA and RELB in spheroid and adherent ovarian cancer
2023-04-28 | GSE230678 | GEO
Unknown Progressive heterogeneity of cancer-initiating cells revealed by quantitative clonal analysis
2022-08-06 | GSE210409 | GEO
Genomics LGR5 marks targetable tumor-initiating cells in liver cancer
| PRJNA565776 | ENA
Transcriptomics Expression data from mouse liver tumor-initiating cells
2013-03-30 | E-GEOD-45646 | biostudies-arrayexpress
Transcriptomics Genome-wide methylation and expression profiling study identifies candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer.
2011-12-20 | E-GEOD-28648 | biostudies-arrayexpress